Ucb, Inc. v. Actavis Laboratories Ut, Inc. ( 2023 )

Case: 21-1924 Document: 72 Page: 1 Filed: 06/16/2023 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ June 16, 2023 ERRATA ______________________ Appeal No. 21-1924 UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee ------------------------------------------------- Appeal No. 21-2336 UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. MYLAN TECHNOLOGIES INC., Defendant-Appellee ______________________ Decided: April 12, 2023 Precedential Opinion ______________________ Case: 21-1924 Document: 72 Page: 2 Filed: 06/16/2023 2 UCB, INC. v. ACTAVIS LABORATORIES UT, INC. Please make the following change to the caption in the opinion and judgment issued April 12, 2023, and the order granting an extension of time issued May 8, 2023: 1 UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee ______________________ 2021-1924 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-00474-KAJ, Circuit Judge Kent A. Jordan. ----------------------------------------------- UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. MYLAN TECHNOLOGIES INC., Defendant-Appellee ______________________ 2021-2336 ______________________ Appeal from the United States District Court for the District of Vermont in No. 2:19-cv-00128-cr, Judge Chris- tina Reiss. 1 The originating tribunal information has been cor- rected to state that Appeal No. 2021-2336 originated from the United States District Court for the District of Ver- mont.